Why the study?
The prevalence of arrhythmias in pregnant women is rising, driven by physiological changes that increase the risk of both benign and pathologic arrhythmias.
Provides a comprehensive overview of the diagnosis and management of cardiac arrhythmias during pregnancy, including pharmacotherapy and electrophysiological procedures.
Offers a reference for arrhythmia management in pregnancy; leaves open the need for prospective trials on safety and outcomes.
The prevalence of arrhythmias in pregnant women are rising, particularly among women with a history of structural heart disease or prior arrhythmia. The physiological changes of pregnancy increase the risk of both benign and pathologic arrhythmias, with atrial fibrillation representing the most common pathologic arrhythmia. While bradyarrhythmias rarely require treatment during pregnancy, pharmacotherapy is frequently required for tachyarrhythmias. Electrophysiological procedures including cardioversions, ablations, and device placement are occasionally required during pregnancy and can be performed safely with proper precautions. This chapter will discuss the diagnosis and management of a broad array of cardiac arrhythmias that may be encountered in pregnant women.
No takes yet. Share an insight, caveat, or question.
Lindley et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: